Collegium Pharmaceutical Inc
COLLHealthcare|Drug Manufacturers - Specialty & Generic|USA
$35.22
-0.59 (-1.65%)
DCF (FCF)
$54.10
Earnings Power
$22.35
About
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
Stock Price
+6.7%(1Y)
Pipeline Summary
37 total trials0
Phase 1
0
Phase 2
9
Phase 3
9
Phase 4
Completed: 17Terminated: 3Recruiting: 5Unknown: 11NOT_YET_RECRUITING: 1
Active Trials (5)
The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction.
NCT06442319ACL Injury
N/ARecruiting
Enrollment: 60 participants
Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)
NCT07593352IBD and Renal Involement
Recruiting
Enrollment: 6,000 participants
Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI
NCT07231939Coronary Artery Disease
Recruiting
Enrollment: 4,000 participants
Analysis of Selected Biochemical Parameters in Cerebrospinal Fluid and Peripheral Blood in the Treatment of Neuropathic Pain Using Spinal Cord Stimulation (SCS)
NCT07153211Neuropathic Pain
N/ARecruiting
Enrollment: 30 participants
Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment
NCT05905965Metabolic Syndrome
Phase 3Recruiting
Enrollment: 200 participants
BioScore
5.8/10
Watchlist
Ownership
Recent Insider Trades
Freund John GordonSELL
2026-05-1820 shares @ $34.05
Freund John GordonSELL
2026-05-154,127 shares @ $34.54
Lurker NancySELL
2026-05-134,500 shares @ $35.97
BOHLIN GAREN GSELL
2026-05-118,700 shares @ $37.18
Dieter DavidSELL
2026-03-1813,976 shares @ $34.92
Data last updated: Jul 12, 2026, 07:36 PM